Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

102.57
+0.33000.32%
Volume:31.95K
Turnover:3.27M
Market Cap:1.68B
PE:9.55
High:103.20
Open:101.86
Low:101.30
Close:102.24
52wk High:108.66
52wk Low:69.02
Shares:16.35M
Float Shares:16.35M
Volume Ratio:0.45
T/O Rate:0.20%
Dividend:1.43
Dividend Rate:1.40%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Retension Pharmaceuticals, TRex Bio File for US IPO as Biotech Momentum Continues

Reuters
·
Sep 19

3 ‘Strong Buy’ Dividend Aristocrat Stocks to Generate Steady Cash

TIPRANKS
·
Sep 19

Sector Update: Healthcare

MT Newswires Live
·
Sep 19

Eli Lilly reports full FDA approval of Inluriyo combo for certain breast cancers

TIPRANKS
·
Sep 19

US FDA Approves Lilly Inluriyo-Verzenio Combo for ESR1-Mutated Metastatic Breast Cancer

Reuters
·
Sep 19

U.S. FDA Approves Inluriyo (Imlunestrant) in Combination with Verzenio (Abemaciclib) for Adults with Er+, Her2-, Esr1-Mutated Advanced or Metastatic Breast Cancer

THOMSON REUTERS
·
Sep 19

Eli Lilly - Inluriyo with Verzenio NOW Available in the United States

THOMSON REUTERS
·
Sep 19

Bloomsbury Publishing (BMY) Gets a Buy from Berenberg Bank

TIPRANKS
·
Sep 18

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Sep 18

Bristol Myers Squibb to Report Q3 Results, Host Earnings Call

Reuters
·
Sep 18

Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026

THOMSON REUTERS
·
Sep 18

Merck Says EU CHMP Backs Keytruda-Padcev Perioperative Use in Resectable Muscle-Invasive Bladder Cancer

Reuters
·
Sep 18

Merck & Co - Final Ec Decision Expected by Q4 2026

THOMSON REUTERS
·
Sep 18

Merck Receives Positive EU Chmp Opinion for Keytruda® (Pembrolizumab) Plus Padcev® (Enfortumab Vedotin-Ejfv) as Perioperative Treatment for Adults with Resectable Muscle-Invasive Bladder Cancer (Mibc)

THOMSON REUTERS
·
Sep 18

Merck Launches Your Hive of Whole Health to Support Whole Person Care for People Living with Hiv

THOMSON REUTERS
·
Sep 18

All 50 States Sign up for Trump's Medicaid Most-Favored-Nation Plan

Reuters
·
Sep 18

When Weight Loss Isn't the Goal of Taking a GLP-1

Dow Jones
·
Sep 18

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 18

Bristol-Myers Squibb Announces R$ 2.15-Per-Unit Dividend for Q4 2026

Reuters
·
Sep 18

Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 18